{"id":"https://openalex.org/W1994768475","doi":"https://doi.org/10.1358/dnp.2005.18.4.908661","title":"The Involvement of Glutamate in the Pathophysiology of Depression","display_name":"The Involvement of Glutamate in the Pathophysiology of Depression","alternate_titles":[],"publication_year":2005,"publication_date":"2005-05-01","ids":{"openalex":"https://openalex.org/W1994768475","doi":"https://doi.org/10.1358/dnp.2005.18.4.908661","mag":"1994768475","pmid":"https://pubmed.ncbi.nlm.nih.gov/16034483"},"language":"en","primary_location":{"id":"doi:10.1358/dnp.2005.18.4.908661","doi":"https://doi.org/10.1358/dnp.2005.18.4.908661","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dnp.2005.18.4.908661","pdf_url":null,"source":{"id":"https://openalex.org/S51538572","display_name":"Drug News & Perspectives","issn_l":"0214-0934","issn":["0214-0934","2013-0139"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug News &amp; Perspectives","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994768475"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052898318","display_name":"Agnieszka Pa\u0142ucha-Poniewiera","orcid":"https://orcid.org/0000-0001-9890-6844","observed_orcids":["https://orcid.org/0000-0001-9890-6844"]},"institutions":[{"id":"https://openalex.org/I4210120768","display_name":"Maj Institute of Pharmacology","ror":"https://ror.org/0288swk05","country_code":"PL","type":"facility","lineage":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]},{"id":"https://openalex.org/I99542240","display_name":"Polish Academy of Sciences","ror":"https://ror.org/01dr6c206","country_code":"PL","type":"government","lineage":["https://openalex.org/I99542240"]}],"countries":["PL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Palucha","raw_affiliation_strings":["Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland. nfpaluch@cyf-kr.edu.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland. nfpaluch@cyf-kr.edu.pl","institution_ids":["https://openalex.org/I4210120768","https://openalex.org/I99542240"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082517862","display_name":"Andrzej Pilc","orcid":"https://orcid.org/0000-0002-4045-0597","observed_orcids":["https://orcid.org/0000-0002-4045-0597"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Pilc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.3023,"has_fulltext":false,"cited_by_count":89,"citation_normalized_percentile":{"value":0.9618358,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"18","issue":"4","first_page":"262","last_page":"262"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.8220000267028809},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8029999732971191},{"id":"https://openalex.org/keywords/glutamatergic-system","display_name":"glutamatergic system","score":0.9589999914169312},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.6370000243186951},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9710000157356262},{"id":"https://openalex.org/keywords/ampa-receptor-potentiators","display_name":"AMPA receptor potentiators","score":0.9789999723434448},{"id":"https://openalex.org/keywords/metabotropic-glutamate-receptors","display_name":"metabotropic glutamate receptors","score":0.996999979019165},{"id":"https://openalex.org/keywords/newer-antidepressants","display_name":"newer antidepressants","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.6860675811767578},{"id":"https://openalex.org/C164718446","wikidata":"https://www.wikidata.org/wiki/Q7234839","display_name":"Potentiator","level":2,"score":0.612455427646637},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.5917518138885498},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.5809434652328491},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5802969932556152},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.5506366491317749},{"id":"https://openalex.org/C115955781","wikidata":"https://www.wikidata.org/wiki/Q6063798","display_name":"Ionotropic effect","level":4,"score":0.5377066731452942},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.5171101093292236},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.5157852172851562},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4900459051132202},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.4757097363471985},{"id":"https://openalex.org/C41653306","wikidata":"https://www.wikidata.org/wiki/Q6589190","display_name":"Metabotropic glutamate receptor 5","level":5,"score":0.4721646010875702},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46669796109199524},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4227159321308136},{"id":"https://openalex.org/C2778875871","wikidata":"https://www.wikidata.org/wiki/Q4764954","display_name":"Animal models of depression","level":4,"score":0.41416630148887634},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.37709367275238037},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30898603796958923},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22737184166908264},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.13097620010375977},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019208","descriptor_name":"Brain-Derived Neurotrophic Factor","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1358/dnp.2005.18.4.908661","doi":"https://doi.org/10.1358/dnp.2005.18.4.908661","is_oa":false,"landing_page_url":"https://doi.org/10.1358/dnp.2005.18.4.908661","pdf_url":null,"source":{"id":"https://openalex.org/S51538572","display_name":"Drug News & Perspectives","issn_l":"0214-0934","issn":["0214-0934","2013-0139"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug News &amp; Perspectives","raw_type":"journal-article"},{"id":"pmid:16034483","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16034483","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug news & perspectives","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2126518605","https://openalex.org/W2365539300","https://openalex.org/W1998246469","https://openalex.org/W2414030574","https://openalex.org/W2020093364","https://openalex.org/W2400067556","https://openalex.org/W3181102098","https://openalex.org/W3033338354","https://openalex.org/W4399739807","https://openalex.org/W4402218050"],"abstract_inverted_index":{"In":[0,103],"spite":[1],"of":[2,7,21,31,40,44,114,119],"more":[3],"than":[4],"40":[5],"years":[6],"thorough":[8],"studies,":[9],"conventional":[10],"antidepressants":[11],"still":[12],"have":[13],"many":[14],"limitations":[15],"that":[16,25,47],"hinder":[17],"the":[18,29,48,112,117],"effective":[19],"treatment":[20],"depression.":[22,41],"It":[23],"seems":[24],"a":[26,37,53,57],"breakthrough":[27],"in":[28,96,116],"therapy":[30],"depression":[32,120],"will":[33],"require":[34],"going":[35],"beyond":[36],"monoamine-based":[38],"theory":[39],"Converging":[42],"lines":[43],"evidence":[45],"indicate":[46],"glutamatergic":[49],"system":[50],"might":[51],"be":[52],"promising":[54],"target":[55],"for":[56],"novel":[58],"antidepressant":[59],"therapy.":[60],"Both":[61],"ionotropic":[62],"glutamate":[63,79,115],"receptor":[64,68,72],"ligands":[65],"(functional":[66],"NMDA":[67],"antagonists":[69,88],"and":[70,74,89,99,108],"AMPA":[71],"potentiators)":[73],"compounds":[75],"acting":[76],"at":[77],"metabotropic":[78],"receptors":[80],"(mGluRs;":[81],"group":[82,86,90],"I":[83],"mGluR":[84],"antagonists,":[85],"II":[87],"III":[91],"agonists)":[92],"produce":[93],"antidepressant-like":[94],"activity":[95],"several":[97],"preclinical":[98],"some":[100],"clinical":[101],"studies.":[102],"this":[104],"review,":[105],"current":[106],"knowledge":[107],"crucial":[109],"hypotheses":[110],"concerning":[111],"role":[113],"pathophysiology":[118],"are":[121],"discussed.":[122]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994768475","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
